Ping An Healthcare and Technology Company Limited (HK:1833)
:1833
Want to see HK:1833 full AI Analyst Report?
Top Page
Ping An Healthcare and Technology Company
(1833)
Select Model
Select Model
Rating:55Neutral
Price Target:
HK$11.00
▼(-8.71% Downside)
Action:ReiteratedDate:03/27/26
The score is mainly supported by improving profitability and cash flow with very low leverage, but is held back by weak technical trend signals (price below all key moving averages and negative MACD) and a high P/E without dividend yield support.
Positive Factors
Very low leverage / strong balance sheet
Extremely low debt-to-equity (~0.4% in 2025) materially reduces financial risk and preserves flexibility. This durable capital structure supports funding operations, product development, and M&A without urgent refinancing, improving resilience through medium-term cycles.
Negative Factors
Top-line volatility and uneven revenue history
A history of sharp contraction then uneven recovery shows the business faces demand or execution variability. Persistent top-line volatility undermines forecasting, makes margin leverage harder to predict, and raises execution risk for sustaining profits over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage / strong balance sheet
Extremely low debt-to-equity (~0.4% in 2025) materially reduces financial risk and preserves flexibility. This durable capital structure supports funding operations, product development, and M&A without urgent refinancing, improving resilience through medium-term cycles.
Read all positive factors
Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$23.24B
Dividend YieldN/A
Average Volume (3M)17.30M
Price to Earnings (P/E)70.4
Beta (1Y)1.24
Revenue Growth13.84%
EPS Growth146.34%
CountryHK
Employees1,563
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,161,443,600
10 Day Avg. Volume8,945,339
30 Day Avg. Volume17,297,252
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.62
Price to Sales (P/S)4.89
P/FCF Ratio66.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$16.83Price Target Upside39.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)0.21
Revenue Forecast (FY)HK$6.00B
Ping An Healthcare and Technology Company Business Overview & Revenue Model
Company Description
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such as online consultation, hospital referral...
How the Company Makes Money
null...
Ping An Healthcare and Technology Company Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
82
Very Positive
Cash Flow
60
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.33B | 4.81B | 4.67B | 6.21B | 7.33B |
| Gross Profit | 1.73B | 1.52B | 1.51B | 1.67B | 1.71B |
| EBITDA | 255.49M | 193.43M | -164.23M | -1.05B | -1.76B |
| Net Income | 369.69M | 81.43M | -322.59M | -636.06M | -1.54B |
Balance Sheet | |||||
| Total Assets | 13.24B | 16.78B | 16.52B | 17.14B | 17.88B |
| Cash, Cash Equivalents and Short-Term Investments | 6.97B | 11.52B | 11.35B | 10.14B | 10.14B |
| Total Debt | 39.81M | 45.00M | 93.61M | 176.49M | 201.29M |
| Total Liabilities | 3.33B | 13.20B | 3.25B | 3.68B | 3.79B |
| Stockholders Equity | 9.92B | 3.59B | 13.28B | 13.46B | 14.08B |
Cash Flow | |||||
| Free Cash Flow | 391.83M | 65.08M | -325.82M | -845.05M | -1.49B |
| Operating Cash Flow | 430.72M | 99.33M | -282.86M | -810.62M | -1.40B |
| Investing Cash Flow | 3.04B | 114.65M | -1.49B | 1.71B | -3.10B |
| Financing Cash Flow | -3.84B | -38.44M | -67.36M | -317.88M | -319.91M |
Ping An Healthcare and Technology Company Technical Analysis
Neutral
12.05
Price Trends
12.63
Negative
13.88
Negative
14.51
Negative
Market Momentum
-0.17
Negative
48.56
Neutral
59.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Neutral. The current price of 12.05 is above the 20-day moving average (MA) of 11.93, below the 50-day MA of 12.63, and below the 200-day MA of 14.51, indicating a neutral trend. The MACD of -0.17 indicates Negative momentum. The RSI at 48.56 is Neutral, neither overbought nor oversold. The STOCH value of 59.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1833.
Ping An Healthcare and Technology Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$6.39B | 19.61 | 6.83% | 2.72% | 15.04% | 5.57% | |
66 Neutral | HK$1.51B | 4.60 | 39.78% | 9.92% | -23.31% | -44.61% | |
62 Neutral | HK$1.38B | -26.14 | -11.93% | ― | 4.75% | 87.06% | |
55 Neutral | HK$23.24B | 70.40 | 3.83% | ― | 13.84% | 146.34% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | HK$6.52B | -110.24 | -2.28% | ― | -4.99% | 47.18% |
* Healthcare Sector Average
HK:1833
Ping An Healthcare and Technology Company
10.75
3.20
42.38%
HK:9886
Dingdang Health Technology Group Ltd.
1.06
0.70
194.44%
HK:1830
Perfect Medical Health Management Limited
1.20
-0.81
-40.30%
HK:2158
Yidu Tech, Inc.
6.12
0.10
1.66%
HK:2192
Medlive Technology Co., Ltd.
8.64
-3.39
-28.18%
HK:2506
Xunfei Healthcare Technology Co., Ltd.
72.35
-38.45
-34.70%
Ping An Healthcare and Technology Company Corporate Events
Ping An Healthcare Shifts Hong Kong Office and Appoints New Process Agent
Apr 23, 2026
Ping An Healthcare and Technology Company Limited has relocated its principal place of business in Hong Kong to the 40th Floor of Dah Sing Financial Centre in Wanchai, effective 23 April 2026. The move may reflect ongoing operational adjustments a...
Ping An Healthcare Delivers Strong Q1 2026 Profit Growth on Insurance Synergy and AI-Driven Health Services
Apr 23, 2026
Ping An Healthcare and Technology Company reported first-quarter 2026 revenue of RMB1.16 billion, up 9.1% year on year, with net profit more than doubling to RMB79.1 million and adjusted net profit rising 45.8% to RMB84.4 million. Management attri...
Ping An Healthcare Shareholders Approve All AGM Resolutions, Renew Capital Mandates
Apr 23, 2026
Ping An Healthcare and Technology Company shareholders approved all resolutions at the 23 April 2026 annual general meeting in Shanghai, with approximately 59.7% of issued shares represented in person or by proxy. The meeting endorsed the 2025 aud...
Ping An Healthcare and Technology Sets Board Meeting to Approve Q1 2026 Results
Apr 10, 2026
Ping An Healthcare and Technology Company has scheduled a board meeting for 23 April 2026 to review, approve and publish the group’s first-quarter results for the period ended 31 March 2026. The meeting will also address any additional board...
Ping An Healthcare sets 2026 AGM to renew board, auditor and share issuance mandate
Mar 30, 2026
Ping An Healthcare and Technology Company Limited has convened its annual general meeting for 23 April 2026 in Shanghai, where shareholders will review the audited consolidated financial statements for the year ended 31 December 2025 and consider ...
Ping An Healthcare and Technology Publishes 2025 Audited Annual Results
Mar 24, 2026
Ping An Healthcare and Technology Company Limited has released its audited annual results for the year ended 31 December 2025, fulfilling Hong Kong listing disclosure requirements with a full annual report that includes financial statements, manag...
Ping An Healthcare Sets RMB8.99 Million Cap on 2026 Intra-Group Services Deal
Mar 24, 2026
Ping An Healthcare and Technology’s wholly owned subsidiary Kang Jian has signed a 2026 services purchasing agreement with controlling shareholder Ping An, under which Ping An will continue providing financial, administrative, risk consultin...
Ping An Healthcare Reshapes Board Secretariat With New Company Secretary
Mar 24, 2026
Ping An Healthcare and Technology Company has announced a change in key governance roles, with Cheng Liu stepping down as secretary of the Board, company secretary and authorised representative due to personal work arrangements, effective 24 March...
Ping An Healthcare and Technology Sets March Board Meeting for 2025 Results and Dividend Decision
Mar 2, 2026
Ping An Healthcare and Technology Company Limited has scheduled a board meeting for 24 March 2026 to review and approve the Group’s annual results for the financial year ended 31 December 2025. The board will also consider the declaration of...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.